These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38887178)

  • 1. Non-Invasive Detection of Early-Stage Fatty Liver Disease via an On-Skin Impedance Sensor and Attention-Based Deep Learning.
    Wang K; Margolis S; Cho JM; Wang S; Arianpour B; Jabalera A; Yin J; Hong W; Zhang Y; Zhao P; Zhu E; Reddy S; Hsiai TK
    Adv Sci (Weinh); 2024 Jun; ():e2400596. PubMed ID: 38887178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Deep Learning in Quantitative Analysis of 2-Dimensional Ultrasound Imaging of Nonalcoholic Fatty Liver Disease.
    Cao W; An X; Cong L; Lyu C; Zhou Q; Guo R
    J Ultrasound Med; 2020 Jan; 39(1):51-59. PubMed ID: 31222786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR.
    Chen P; Li Y; Xiao L
    Exp Ther Med; 2021 Oct; 22(4):1109. PubMed ID: 34504563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population.
    Yang Y; Liu J; Sun C; Shi Y; Hsing JC; Kamya A; Keller CA; Antil N; Rubin D; Wang H; Ying H; Zhao X; Wu YH; Nguyen M; Lu Y; Yang F; Huang P; Hsing AW; Wu J; Zhu S
    Eur Radiol; 2023 Aug; 33(8):5894-5906. PubMed ID: 36892645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease test: an external validation cohort.
    Polyzos SA; Papaefthymiou A; Doulberis M; Kountouras J
    Hormones (Athens); 2024 Mar; 23(1):131-136. PubMed ID: 37953360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence model with deep learning in nonalcoholic fatty liver disease diagnosis: genetic based artificial neural networks.
    Ülger Y; Delik A
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(5):398-406. PubMed ID: 36448439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome.
    Moolla A; de Boer J; Pavlov D; Amin A; Taylor A; Gilligan L; Hughes B; Ryan J; Barnes E; Hassan-Smith Z; Grove J; Aithal GP; Verrijken A; Francque S; Van Gaal L; Armstrong MJ; Newsome PN; Cobbold JF; Arlt W; Biehl M; Tomlinson JW
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1188-1197. PubMed ID: 32298002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
    World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective.
    Wang JL; Jiang SW; Hu AR; Zhou AW; Hu T; Li HS; Fan Y; Lin K
    Heliyon; 2024 Mar; 10(5):e27325. PubMed ID: 38449611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis.
    Guan MC; Ouyang W; Liu SY; Sun LY; Chen WY; Tong XM; Zhu H; Yang T
    Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):559-568. PubMed ID: 35643910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales.
    Michalak A; Cichoż-Lach H; Guz M; Kozicka J; Cybulski M; Jeleniewicz W; Stepulak A
    World J Gastroenterol; 2020 Dec; 26(47):7538-7549. PubMed ID: 33384553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models.
    Nachit M; De Rudder M; Thissen JP; Schakman O; Bouzin C; Horsmans Y; Vande Velde G; Leclercq IA
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):144-158. PubMed ID: 33244884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Nonalcoholic Fatty Liver Disease by Anthropometric Indices and Bioelectrical Impedance Analysis in Children.
    Lee LW; Yen JB; Lu HK; Liao YS
    Child Obes; 2021 Dec; 17(8):551-558. PubMed ID: 34265208
    [No Abstract]   [Full Text] [Related]  

  • 15. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease.
    Jayasekera D; Hartmann P
    World J Hepatol; 2023 May; 15(5):609-640. PubMed ID: 37305367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Invasive Electrical Impedance Tomography for Multi-Scale Detection of Liver Fat Content.
    Luo Y; Abiri P; Zhang S; Chang CC; Kaboodrangi AH; Li R; Sahib AK; Bui A; Kumar R; Woo M; Li Z; Packard RRS; Tai YC; Hsiai TK
    Theranostics; 2018; 8(6):1636-1647. PubMed ID: 29556346
    [No Abstract]   [Full Text] [Related]  

  • 17. Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults.
    Qin S; Hou X; Wen Y; Wang C; Tan X; Tian H; Ao Q; Li J; Chu S
    Sci Rep; 2023 Mar; 13(1):3638. PubMed ID: 36869105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
    Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
    JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
    Hu C; Wang T; Zhuang X; Sun Q; Wang X; Lin H; Feng M; Zhang J; Cao Q; Jiang Y
    J Transl Med; 2021 Apr; 19(1):152. PubMed ID: 33858428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention Cost-Sensitive Deep Learning-Based Approach for Skin Cancer Detection and Classification.
    Ravi V
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.